Anaptysbio (ANAB) Net Margin (2016 - 2025)
Anaptysbio's Net Margin history spans 10 years, with the latest figure at 83.58% for Q4 2025.
- For Q4 2025, Net Margin rose 17071.0% year-over-year to 83.58%; the TTM value through Dec 2025 reached 0.09%, up 24966.0%, while the annual FY2025 figure was 0.07%, 15904.0% up from the prior year.
- Net Margin reached 83.58% in Q4 2025 per ANAB's latest filing, up from 30.23% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 83.58% in Q4 2025 to a low of 3237.84% in Q1 2022.
- Average Net Margin over 5 years is 923.94%, with a median of 433.99% recorded in 2022.
- Peak YoY movement for Net Margin: crashed -313115bps in 2021, then skyrocketed 263239bps in 2022.
- A 5-year view of Net Margin shows it stood at 3075.07% in 2021, then skyrocketed by 86bps to 442.68% in 2022, then dropped by -6bps to 468.27% in 2023, then skyrocketed by 81bps to 87.14% in 2024, then skyrocketed by 196bps to 83.58% in 2025.
- Per Business Quant, the three most recent readings for ANAB's Net Margin are 83.58% (Q4 2025), 30.23% (Q3 2025), and 173.52% (Q2 2025).